Evidence-Based Commentary: Testing and Treating Latent Tuberculosis Before Starting Biologics and Small Molecules in Patients with Inflammatory Bowel Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Evidence-Based Commentary: Testing and Treating Latent Tuberculosis Before Starting Biologics and Small Molecules in Patients with Inflammatory Bowel Disease ; volume:12 ; number:02 ; year:2022 ; pages:128-132
Journal of Gastrointestinal Infections ; 12, Heft 02 (2022), 128-132
- Beteiligte Personen und Organisationen
-
Kakadiya, Rinkalben
Sharma, Vishal
- DOI
-
10.1055/s-0043-1760741
- URN
-
urn:nbn:de:101:1-2024030112043085851044
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kakadiya, Rinkalben
- Sharma, Vishal
Ähnliche Objekte (12)
Evidence-based therapy of Psoriasis: focus on biologics
Evidence-Based Commentary: Testing for Clostridioides difficile Infection
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
Evidence-Based Commentary: Antibiotics for Prophylaxis of Spontaneous Bacterial Peritonitis
Biologics in therapy
Moderne Antipsoriatika : Schwerpunkt Biologics
Biologics in der Dermatologie
Adverse reactions to biologics
Biologics in der Dermatologie
Evidence-Based Commentary: Ascitic Adenosine Deaminase in the Diagnosis of Peritoneal Tuberculosis
Starting, Heinz
Evidence-based therapy of Psoriasis: focus on biologics
Evidence-Based Commentary: Testing for Clostridioides difficile Infection
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
Evidence-Based Commentary: Antibiotics for Prophylaxis of Spontaneous Bacterial Peritonitis
Biologics in therapy
Moderne Antipsoriatika : Schwerpunkt Biologics
Biologics in der Dermatologie
Adverse reactions to biologics
Biologics in der Dermatologie
Evidence-Based Commentary: Ascitic Adenosine Deaminase in the Diagnosis of Peritoneal Tuberculosis
Starting, Heinz
Evidence-based therapy of Psoriasis: focus on biologics
Evidence-Based Commentary: Testing for Clostridioides difficile Infection
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
Evidence-Based Commentary: Antibiotics for Prophylaxis of Spontaneous Bacterial Peritonitis
Biologics in therapy
Moderne Antipsoriatika : Schwerpunkt Biologics
Biologics in der Dermatologie
Adverse reactions to biologics
Biologics in der Dermatologie
Evidence-Based Commentary: Ascitic Adenosine Deaminase in the Diagnosis of Peritoneal Tuberculosis